ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,734,000 | -35.9% | 61,700 | -58.9% | 0.02% | -40.6% |
| Q3 2021 | $8,939,000 | +443.7% | 150,100 | +522.8% | 0.03% | +433.3% |
| Q2 2021 | $1,644,000 | -59.9% | 24,100 | -59.2% | 0.01% | -68.4% |
| Q1 2021 | $4,098,000 | +79.6% | 59,062 | +98.9% | 0.02% | +90.0% |
| Q4 2020 | $2,282,000 | +377.4% | 29,700 | +364.1% | 0.01% | +400.0% |
| Q3 2020 | $478,000 | +124.4% | 6,400 | +36.2% | 0.00% | 0.0% |
| Q4 2019 | $213,000 | -36.6% | 4,700 | -35.9% | 0.00% | -33.3% |
| Q3 2019 | $336,000 | +52.7% | 7,333 | +96.1% | 0.00% | +50.0% |
| Q2 2019 | $220,000 | -46.6% | 3,740 | -59.3% | 0.00% | -33.3% |
| Q1 2019 | $412,000 | -20.8% | 9,200 | -31.0% | 0.00% | 0.0% |
| Q4 2018 | $520,000 | – | 13,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |